DNAJB9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.553400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.325200E-01
Normal-vs-Stage2
4.422000E-01
Normal-vs-Stage3
9.904000E-01
Normal-vs-Stage4
2.514200E-01
Stage1-vs-Stage2
6.168600E-01
Stage1-vs-Stage3
1.618590E-01
Stage1-vs-Stage4
9.311400E-01
Stage2-vs-Stage3
3.702200E-01
Stage2-vs-Stage4
7.438200E-01
Stage3-vs-Stage4
1.732020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.622800E-01
Normal-vs-AfricanAmerican
1.196610E-01
Normal-vs-Asian
9.611600E-01
Caucasian-vs-AfricanAmerican
2.454400E-01
Caucasian-vs-Asian
1.866030E-01
AfricanAmerican-vs-Asian
2.894500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.414000E-01
Normal-vs-Female
4.724200E-01
Male-vs-Female
5.266600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.987800E-01
Normal-vs-Age(41-60Yrs)
3.369400E-01
Normal-vs-Age(61-80Yrs)
4.820400E-01
Normal-vs-Age(81-100Yrs)
9.681000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.438200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.062200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.529570E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.794300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.615400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.310200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.930000E-01
Normal-vs-Daily Drinker
6.575000E-01
Normal-vs-Weekly Drinker
8.526400E-01
Normal-vs-Occasional Drinker
4.788800E-01
Normal-vs-Social Drinker
4.849800E-01
Non Drinker-vs-Daily Drinker
6.690400E-01
Non Drinker-vs-Weekly Drinker
5.225200E-01
Non Drinker-vs-Occasional Drinker
1.885210E-01
Non Drinker-vs-Social Drinker
2.332400E-01
Daily Drinker-vs-Weekly Drinker
4.158800E-01
Daily Drinker-vs-Occasional Drinker
3.166400E-01
Daily Drinker-vs-Social Drinker
3.587600E-01
Weekly Drinker-vs-Occasional Drinker
1.289770E-01
Weekly Drinker-vs-Social Drinker
1.672230E-01
Occasional Drinker-vs-Social Drinker
9.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.638400E-01
Normal-vs-Grade 2
5.784200E-02
Normal-vs-Grade 3
9.131500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.544100E-02
Grade 1-vs-Grade 3
4.861600E-02
Grade 1-vs-Grade 4
2.638400E-01
Grade 2-vs-Grade 3
4.692400E-01
Grade 2-vs-Grade 4
5.784200E-02
Grade 3-vs-Grade 4
9.131500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.747400E-01
Normal-vs-NonDiabetic
5.062800E-01
Diabetic-vs-NonDiabetic
9.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.109000E-01
Normal-vs-NoPancreatitis
4.951200E-01
Pancreatitis-vs-NoPancreatitis
9.142700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.699400E-01
Normal-vs-N1
4.305400E-01
N0-vs-N1
4.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.520200E-01
Normal-vs-TP53-NonMutant
1.795860E-02
TP53-Mutant-vs-TP53-NonMutant
3.901800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
